Development and evaluation of the essential oil from Magnolia fargesii for enhancing the transdermal absorption of theophylline and cianidanol

J Pharm Pharmacol. 2004 Dec;56(12):1493-500. doi: 10.1211/0022357044823.

Abstract

To improve the skin permeation of theophylline and cianidanol ((+)-catechin), the essential oil of Magnolia fargesii was evaluated using in-vitro and in-vivo permeation techniques. Oxygenated monoterpenes and sesquiterpenes are the major components of M. fargesii essential oil. The in-vitro permeation of theophylline and cianidanol was significantly enhanced after treatment with M. fargesii essential oil. The essential oil increased the in-vivo skin deposition of cianidanol but not theophylline. On the other hand, in-vivo microdialysis showed a higher subcutaneous theophylline amount after essential oil treatment. In-vitro cell viability and prostaglandin E(2) release by skin keratinocytes indicated that there was low or negligible cytotoxicity by M. fargesii essential oil. The in-vivo skin tolerance study determined by transepidermal water loss and colorimetry confirmed that no irritation of the skin was detected when using M. fargesii essential oil.

Publication types

  • Comparative Study

MeSH terms

  • Administration, Cutaneous
  • Animals
  • Catechin / administration & dosage
  • Catechin / pharmacokinetics*
  • Cell Culture Techniques / methods
  • Dose-Response Relationship, Drug
  • Drug Evaluation, Preclinical / methods
  • Drug Synergism
  • Female
  • Humans
  • Magnolia*
  • Oils, Volatile / administration & dosage
  • Oils, Volatile / pharmacokinetics*
  • Rats
  • Rats, Wistar
  • Skin Absorption / drug effects
  • Skin Absorption / physiology*
  • Theophylline / administration & dosage
  • Theophylline / pharmacokinetics*

Substances

  • Oils, Volatile
  • Catechin
  • Theophylline